Xtant Medical to Issue Fourth Quarter and Full Year 2023 Financial Results on April 1, 2024
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for Q4 and full year 2023 on April 1, 2024. The conference call hosted by the President and CFO will discuss the results.
03/21/2024 - 04:05 PM
BELGRADE, Mont., March 21, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2023, before the open of the financial markets on Monday, April 1, 2024.
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Monday, April 1 at 9:00 AM ET to review results.
Conference Details: Conference Date : Monday, April 1, 2024 - 9:00 AM ETConference dial-in : 877-407-6184International dial-in : 201-389-0877Conference Call Name : Xtant Medical Q4 2023 Financial ResultsWebcast Registration : Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com , under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical’s mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (www.xtantmedical.com ) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
David Carey Lazar FINN Partners Ph: 212-867-1762 Email: david.carey@finnpartners.com
When will Xtant Medical Holdings release its financial results for Q4 and full year 2023?
Xtant Medical Holdings will release its financial results for Q4 and full year 2023 on April 1, 2024.
Who will host the conference call to review the financial results?
The conference call to review the financial results will be hosted by Sean Browne, President, and Scott Neils, CFO.
What is the conference call name for Xtant Medical Q4 2023 Financial Results?
The conference call name for Xtant Medical Q4 2023 Financial Results is 'Xtant Medical Q4 2023 Financial Results'.
Where can the replay of the conference call be found?
The replay of the conference call can be found on the Company's website, www.xtantmedical.com, under 'Investor Info'.
Xtant Medical Holdings Inc
XTNT Rankings
#224 Ranked by Stock Gains
XTNT Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Tags
Health Technology, Medical Specialties, Manufacturing, Biological Product (except Diagnostic) Manufacturing
Country
US
City
Belgrade
About XTNT
xtant medical (nyse mkt: xtnt) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries. with core competencies in both biologic and non-biologic surgical technologies, xtant can leverage its resources to successfully compete in global neurological and orthopedic surgery markets. for further information, please visit xtantmedical.com.